ArticleCureus2025
Spectrum of Pure Red Cell Aplasia in a Tertiary Care Hospital in Northeast India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Pure red cell aplasia (PRCA) is an uncommon disorder characterized by severe normocytic normochromic anemia, reticulocytopenia, and an absence of erythroblasts from otherwise normal bone marrow. PRCA can present as either a congenital disorder or an acquired syndrome. Methodology A total of six cases of PRCA diagnosed in a tertiary care hospital from January 2016 to December 2019 were retrospectively studied. The diagnosis of PRCA was made based on bone marrow examinations showing erythroblastopenia with essentially normal myelopoiesis and megakaryopoiesis. Results Of the six patients, one was identified as having congenital PRCA, three were classified as having primary acquired PRCA, and two were diagnosed with secondary acquired PRCA. The congenital case was an infant diagnosed with Diamond-Blackfan anemia (DBA). There were three cases of primary acquired PRCA. One was idiopathic, as no specific cause could be identified. The other primary acquired case had autoimmune hemolytic anemia (AIHA); however, no underlying cause for peripheral hemolysis or secondary causes of marrow suppression could be identified. The third primary case was myelodysplastic PRCA. The causes of secondary acquired PRCA included systemic lupus erythematosus (SLE) and thymoma. Conclusion The present study demonstrates that the causes and outcomes of PRCA are varied; however, they are similar to those observed in other similar series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.